Malcolm Mitchell | Senior Medical Fellow, Clinical Pharmacology Eli Lilly
Malcolm Mitchell is a graduate of Newcastle Medical School, following a decade in the NHS , he joined the pharmaceutical industry over 25 years ago, with positions in Pfizer, NAPP and Lilly. He has been working in clinical pharmacology at Eli Lilly for the past 18 years. He has been involved in ongoing drug development for many aspects of clinical pharmacology through the portfolio. This includes most of the studies performed from FIH through to BE for formulation change, it also has meant both small molecule NCEs and biologicals.
Share this
Appearances at this years' conference:
Thursday 24 May 2012- Day Two
@ 15.00
Assessing safety in FIH clinical trials
- Keep the end in mind
- Review the pharmacological effects observed in toxicology
- Check those toxicology findings
- Be conservative in dosing
› Malcolm Mitchell, Senior Medical Fellow, Clinical Pharmacology, Eli Lilly